United States of America
Dr. Yu has over 20 years of clinical drug development experience and expertise. At ICOS, he was instrumental in the development of Cialis® for the treatment of erectile dysfunction; at Calistoga, he was key for developing Zydelig® for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia. His experience covers a wide spectrum therapeutic areas including Cardiovascular, Central Nervous System, Critical Care, Dermatology, Gastroenterology, Hematology, Infectious Disease, Oncology, Respiratory, Urology, paired with in depth expertise in Clinical Pharmacology. Dr. Yu was Vice President of Clinical Development at Omeros Corporation; Chief Medical Officer and Vice President of Clinical Affairs at Calistoga Pharmaceuticals, Inc.; and Senior Director Clinical Operations, Research & Affairs at ICOS Corporation. Dr. Yu is trained in internal medicine, critical care medicine and pulmonary disease. He received his Bachelor of Science degree in Biology from Massachusetts Institute of Technology and his medical degree from the University of Washington.